A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema

NCT06929143 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

3000

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration (nAMD)
Diabetic Macular Edema (DME)

Interventions

DRUG: Aflibercept (Eylea, BAY86-5321)

Sponsor

Bayer